维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Mcclay EF"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Phase I/ pharmacokinetic study of high-dose progesterone and doxorubicin显示文摘	Christen RD McClay EF Plaxe SC	1993	J Clin Oncol1993，11，：	1
2	A compafison of intravenous vemus intraperitoneal chemothempy for the initial treatment of ovarian cancer显示文摘	Kirinani S Braty PS Mcclay EF	1994	Gynecol Oncol1994，54，3：	1
3	phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma显示文摘	McClay EF McClay MT Monroe L	2001	Melanoma Res2001，，：	1
4	A compafison ofin travenous vemus intraperitonealchemothempy for the initial treatmentofovarian cancer 显示文摘	Kirinani S Braty PS Mcclay EF	1994	Gynecol Oncol1994，54，3：	1
5	A phase Ⅱ trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma 显示文摘	McClay EF Braly PD Kirmani S	1995	Am J Clin Oncol1995，18，1：	1
6	Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials 显示文摘	McClay EF Mastrangelo MJ Berd D	1992	Int J Cancer1992，50，4：	1
7	A comparison of intravenous versus intraperitoneal chemothempy for the initial treatment of ovarian cancer显示文摘	Kirinani S Braty PS Mcclay EF	1994	Gynecol Oncol1994，54，3：	1
8	Tamoxifen modulation of cisplatin cytotoxicity in human malignancies 显示文摘	McClay EF Albright KD Jones JA	1993	Int J Cancer1993，55，6：	1
9	The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high-risk melanoma显示文摘	McClay EF McClay MET Monroel	2000	Br J Cancer2000，83，：	1
10	A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer显示文摘	Kirmani S Braly PS McClay EF	1994	Gynecol Oncol1994，54，3：	1
11	Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma显示文摘	McClay EF McClay MET Albright K	1994	Cancer1994，72，：	1
12	Intraperitoneal cisplatin in the managment of patients with ovarian cancer显示文摘	McClay EF Howell SB	1990	Gynecol Oncol1990，36，：	1
13	A phase Ⅱstudy of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma显示文摘	McClay EF McClay MT Monroe L	2001	Melanoma Res2001，11，3：	1
14	A comparison of intrave?nous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer显示文摘	Kirmani S Braly PS McClay EF	1994	Gynecol Oncol1994，54，3：	1
15	Tamoxifen delays the development of resistance to eisplatin in human melanoma and ovarian cancer cell lines显示文摘	McClay EF Alhright KD Jones JA	1994	Br J Cancer1994，70，3：	1
16	Dendritic versus tumor cell presentation of autologous tumor antigens for active specific im- munotherapy in metastatic melanoma:impact on long-term survival by extent of disease at the time of treatment显示文摘	Dillman RO McClay EF Barth NM	2015	Cancer Biother Radio- pharm2015，30，5：	1
17	The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma显示文摘	McClay EF McClay ME Monroe L	2000	J Cancer2000，83，1：	1
18	A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer 显示文摘	Kirmani S Braly PS McClay EF	1994	Gynecol Oncol1994，54，：	1
19	The effect of tamoxifenand cisplatin on the disease-free and overall survival of patients withhigh risk malignant melanoma显示文摘	McClay EF McClay ME Monroe L	2000	Br J Cancer2000，83，1：	1
20	腹腔注射顺铂治疗卵巢癌显示文摘增加肿瘤与抗癌药物的接触,能提高治疗有效率和存活时间。人类许多肿瘤局限于腹腔、(如卵巢癌和间皮瘤)。腹腔注射(IP)药物增加了这些部位的肿瘤与药物直接接触的机会。药动学研究认为,许多药物通过腹腔给药可显示出不少药理学方面的优点。进一步了解腹腔化疗的原理并应用于临床,能改善病人存活。本文对腹腔化疗药理学原理及应用顺铂腹腔给药治疗卵巢癌进行综述。腹腔药动学将IP治疗视为三室模型。药物直接进入肿瘤所在的腔内为第一室;然后被吸收入血液中(血浆)为第二室;再分布到与血液接触的所有其它组织为第三室。总的药物作用以测定血药浓度时间曲线下面积(AUC)计算。可用腹腔/血浆AUC比说明药物直接注入腹腔内的优点。	McClay EF Howell SB 石钢	1991	国外医学(妇产科学分册)1991，18，4：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示